Dr Shore Discusses Patient Considerations With Radium 223

Neal D. Shore, MD, FACS, Medical Director, Carolina Urologic Research Center, Myrtle Beach, discusses patient considerations following treatment with radium-223 for bone metastases from prostate cancer.

More on prostate cancer: onclive.com/specialty/prostate-cancer

  • Dr. Shore Discusses Patient Considerations With Radium-223 ( Download)
  • Dr. Shore on Patient Considerations Following Treatment With Radium-223 ( Download)
  • Radium-223: Treatment Considerations ( Download)
  • Dr. Shore on the Approval of Radium-223 ( Download)
  • Dr. Neal D. Shore on the Approval of Radium-223 ( Download)
  • ERA 223 Study | Concerns for Using Radium-223 and Abiraterone ( Download)
  • Dr. George Discusses Radium-223 for Patients With mCRPC Part I ( Download)
  • Sartor: Expanded Access Program for Radium-223 (Xofigo) ( Download)
  • Dr. Sartor on Mechanism of Action and Safety of Radium-223 in mCRPC ( Download)
  • Dr. Sartor Discusses the Novel Agent Radium-223 ( Download)
  • Dr. George Discusses Radium-223 for Patients With mCRPC Part II ( Download)
  • Radium-223 for Treatment of Prostate Cancer ( Download)
  • Dr. Vogelzang Discusses Treatment With Radium-223 and Chemotherapy for Prostate Cancer ( Download)
  • Dr. Saad on Radium-223 in Patients with mCRPC ( Download)
  • Bone-migrated prostate cancer and Radium-223 therapy ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com